Immunomedics, Inc. (IMMU) Announces Third Quarter Fiscal 2014 Results And Clinical Program Developments
5/8/2014 10:00:28 AM
MORRIS PLAINS, N.J., May 7, 2014 (GLOBE NEWSWIRE) -- Immunomedics, Inc., (Nasdaq:IMMU) today reported financial results for the third quarter ended March 31, 2014. The Company also highlighted recent key developments and planned activities for its clinical pipeline.
Help employers find you! Check out all the jobs and post your resume.
comments powered by